Treat to Target
Includes a Live Web Event on 02/22/2025 at 9:15 AM (EST) Includes a Live In-Person Event on 02/22/2025 at 9:15 AM (EST)
The concept of treat to target is well recognized across multiple fields of medicine and for some time now has been discussed in the arena of osteoporosis. This lecture will focus on the concept of treat to target in patients who warrant treatment for being at high risk for fracture along with which goals should be assessed and discussed with the patients for optimizing treatment.
OBJECTIVES
- Identify what is considered treat to target in osteoporosis treatment
- Describe the newer position statement published in this field
- Determine how to best assess patients on treatment over time along with treatment goals.Identify currently available software features that have clinical application
LOCATION
Georgian room
E. Michael Lewiecki, MD, FACP, FACE, CCD
Director
New Mexico Clinical Research & Osteoporosis Center, Inc.
E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health TeleECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.
This activity has been approved by ASRT for 1.0 Category A continuing education credits.
If you want to claim credits for ACCME you will be able to at the end of the conference at this link:
https://learn.iscd.org/product...